{"id":3972,"date":"2026-02-16T17:55:46","date_gmt":"2026-02-16T16:55:46","guid":{"rendered":"https:\/\/fhucare.com\/?p=3972"},"modified":"2026-02-23T13:43:52","modified_gmt":"2026-02-23T12:43:52","slug":"conference-du-pr-michel-sadelain-pionnier-de-limmunotherapie-pour-le-traitement-par-car-t-cells-des-cancers-du-sang","status":"publish","type":"post","link":"https:\/\/fhucare.com\/fr\/event\/conference-du-pr-michel-sadelain-pionnier-de-limmunotherapie-pour-le-traitement-par-car-t-cells-des-cancers-du-sang\/","title":{"rendered":"Conf\u00e9rence du Pr Michel Sadelain pionnier de l&rsquo;immunoth\u00e9rapie pour le traitement par CAR-T cells des cancers du sang."},"content":{"rendered":"\n<h2 class=\"wp-block-heading has-x-large-font-size\"><strong>Conf\u00e9rence du Pr Michel Sadelain \u2013 Fondation de l\u2019AP\u2011HP<\/strong><\/h2>\n\n\n\n<p>La Fondation de l\u2019AP\u2011HP a le plaisir d\u2019accueillir le Pr <strong>Michel Sadelain<\/strong>, m\u00e9decin\u2011chercheur de renomm\u00e9e internationale et pionnier des th\u00e9rapies par <strong>CAR\u2011T cells<\/strong> dans les cancers du sang. Il dirige la <strong>Columbia Initiative in Cell Engineering and Therapy<\/strong> \u00e0 l\u2019Universit\u00e9 Columbia.<\/p>\n\n\n\n<p>Revoir le Replay : <em><strong>Pr Michel Sadelain : \u00ab\u00a0Cellules CAR-T anti-CD19 : prototypes du m\u00e9dicament vivant<\/strong><\/em><\/p>\n\n\n\n<figure class=\"wp-block-image aligncenter size-full is-resized\"><a href=\"https:\/\/youtu.be\/kREFRAKQLnE?si=gUwh3EbrXOnMu6Av\" target=\"_blank\" rel=\" noreferrer noopener\"><img loading=\"lazy\" decoding=\"async\" width=\"848\" height=\"466\" src=\"https:\/\/fhucare.com\/wp-content\/uploads\/2026\/02\/image-19.png\" alt=\"\" class=\"wp-image-4557\" style=\"aspect-ratio:1.8198309972503521;width:1176px;height:auto\" srcset=\"https:\/\/fhucare.com\/wp-content\/uploads\/2026\/02\/image-19.png 848w, https:\/\/fhucare.com\/wp-content\/uploads\/2026\/02\/image-19-500x275.png 500w, https:\/\/fhucare.com\/wp-content\/uploads\/2026\/02\/image-19-768x422.png 768w\" sizes=\"auto, (max-width: 848px) 100vw, 848px\" \/><\/a><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-accent-2-color\">Lancement de la strat\u00e9gie MTI@AP\u2011HP<\/mark><\/strong><\/h2>\n\n\n\n<p>La direction g\u00e9n\u00e9rale de l\u2019AP\u2011HP pr\u00e9sentera, le m\u00eame jour, la nouvelle strat\u00e9gie d\u00e9di\u00e9e aux <strong>m\u00e9dicaments de th\u00e9rapie innovante (MTI)<\/strong>. Cette journ\u00e9e rassemblera les \u00e9quipes cliniques, pharmaceutiques, scientifiques et institutionnelles engag\u00e9es dans la mise en \u0153uvre de la feuille de route <strong>MTI@AP\u2011HP<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Programme<\/strong><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>13 h 00 \u2013 Ouverture<\/strong><\/h3>\n\n\n\n<p>Pr\u00e9sentation des engagements de l\u2019AP\u2011HP au b\u00e9n\u00e9fice des patients et des acteurs mobilis\u00e9s autour de la strat\u00e9gie MTI.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>13 h 35 \u2013 14 h 05<\/strong><\/h3>\n\n\n\n<p><strong>Une strat\u00e9gie pour les m\u00e9dicaments de th\u00e9rapie innovante \u00e0 l\u2019AP\u2011HP<\/strong> Intervenants : Nicolas Revel, Pr R\u00e9mi Salomon<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>14 h 10 \u2013 15 h 10<\/strong><\/h3>\n\n\n\n<p><strong>Cinq tableaux flash : Innover sur l\u2019ensemble de la cha\u00eene de valeur<\/strong><\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong>Axe 1 \u2013 Soins : des parcours innovants<\/strong><\/h4>\n\n\n\n<p>Th\u00e9rapie g\u00e9nique \u00e0 domicile : Vyjuvek pour les \u00e9pidermolyses bulleuses \u2013 Pr Christine Bodemer (Necker)<\/p>\n\n\n\n<p>Dossier patient national et registres : Siclop\u00e9die \u2013 Pr Pablo Bartolucci (Henri\u2011Mondor)<\/p>\n\n\n\n<p><\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong>Axe 2 \u2013 Pharmacies \u00e0 usage int\u00e9rieur : innovations organisationnelles<\/strong><\/h4>\n\n\n\n<p>R\u00e9seau de pharmaciens experts et sch\u00e9ma directeur des PUI \u2013 Dr Muriel Carvalho (Henri\u2011Mondor)<\/p>\n\n\n\n<p>Mobilit\u00e9 et accessibilit\u00e9 : MOBIZAC \u2013 Dr Fanny Charbonnier (Piti\u00e9\u2011Salp\u00eatri\u00e8re)<\/p>\n\n\n\n<p><\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong>Axe 3 \u2013 Production et d\u00e9veloppement : ATMP@AP\u2011HP Center<\/strong><\/h4>\n\n\n\n<p>Un ATMP Center pour l\u2019AP\u2011HP \u2013 Pr J\u00e9r\u00f4me Larghero (Saint\u2011Louis)<\/p>\n\n\n\n<p>Acc\u00e8s aux CAR\u2011T pour les maladies non oncologiques p\u00e9diatriques \u2013 Dr Jean\u2011S\u00e9bastien Diana (Necker)<\/p>\n\n\n\n<p>Passage au grade clinique : th\u00e9rapie cellulaire adjuvante en chirurgie in utero du spina bifida \u2013 Dr Yoann Athiel (Trousseau) &amp; Dr Jean\u2011Roch Fabreguettes (Meary)<\/p>\n\n\n\n<p><\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong>Axe 4 \u2013 Recherche et innovation : terrains d\u2019avenir<\/strong><\/h4>\n\n\n\n<p>\u00c9valuation th\u00e9rapeutique des MTI \u2013 Pr Lucie Biard (Saint\u2011Louis)<\/p>\n\n\n\n<p>Recherche translationnelle et ing\u00e9nierie tissulaire \u2013 Pr Jean\u2011Charles Duclos\u2011Vall\u00e9e (Paul\u2011Brousse)<\/p>\n\n\n\n<p><\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong>Axe 5 \u2013 Strat\u00e9gie partenariale : collaborations pour de nouvelles indications<\/strong><\/h4>\n\n\n\n<p>Th\u00e9rapies d\u00e9velopp\u00e9es en propre pour maladies rares : Artegene \u2013 Pr Marina Cavazzana (Necker)<\/p>\n\n\n\n<p>Nouvelles indications des CAR\u2011T : collaboration acad\u00e9mique avec Barcelone \u2013 Pr Andr\u00e9 Baruchel (Robert\u2011Debr\u00e9)<\/p>\n\n\n\n<p><\/p>\n\n\n\n<p><strong>Transition :<\/strong> Une strat\u00e9gie MTI entre amont et aval \u2013 Pr Philippe Menasch\u00e9 (HEGP)<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>15 h 10 \u2013 16 h 00<\/strong><\/h3>\n\n\n\n<p><strong>Table ronde : un engagement collectif<\/strong> Anim\u00e9e par le Pr \u00c9tienne Gayat et le Dr Elisa Magrin<\/p>\n\n\n\n<p>Intervenants :<\/p>\n\n\n\n<p>Renforcer les interactions acad\u00e9miques \u2013 Pr Matthieu Resche\u2011Rigon (Universit\u00e9 Paris Cit\u00e9)<\/p>\n\n\n\n<p>Coop\u00e9ration inter\u2011CHU pour la production et l\u2019investigation MTI \u2013 St\u00e9phanie Decoopman (CHU Rouen)<\/p>\n\n\n\n<p>Synergies public\u2011priv\u00e9 \u2013 Dr Fr\u00e9d\u00e9ric Revah (G\u00e9n\u00e9thon \/ Genother)<\/p>\n\n\n\n<p>Dimension europ\u00e9enne et r\u00e9seau \u00ab Centre of excellence for ATMPs \u00bb \u2013 Pr Christian Jorgensen (IHU Immun4Cure)<\/p>\n\n\n\n<p>Faciliter l\u2019acc\u00e8s des patients aux innovations \u2013 Pr Catherine Paugam (ANSM)<\/p>\n\n\n\n<p><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>16 h 00 \u2013 16 h 10<\/strong><\/h3>\n\n\n\n<p><strong>Regard patients et conclusion<\/strong><\/p>\n\n\n\n<p><\/p>\n\n\n\n<p>Pour toute question :&nbsp;<a href=\"mailto:sap-communication_fondation@aphp.fr\">sap-communication_fondation@aphp.fr<\/a><\/p>\n\n\n\n<p>Plus d&rsquo;infos : <a href=\"https:\/\/www.aphp.fr\/evenements\/invitation-la-conference-du-pr-michel-sadelain-pionnier-de-limmunotherapie-pour-le\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/www.aphp.fr\/evenements\/invitation-la-conference-du-pr-michel-sadelain-pionnier-de-limmunotherapie-pour-le<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Conf\u00e9rence du Pr Michel Sadelain \u2013 Fondation de l\u2019AP\u2011HP La Fondation de l\u2019AP\u2011HP a le plaisir d\u2019accueillir le Pr Michel Sadelain, m\u00e9decin\u2011chercheur de renomm\u00e9e internationale et pionnier des th\u00e9rapies par CAR\u2011T cells dans les cancers du sang. Il dirige la Columbia Initiative in Cell Engineering and Therapy \u00e0 l\u2019Universit\u00e9 Columbia. Revoir le Replay : Pr [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":3970,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"single-post-left-featured-image","format":"standard","meta":{"event_date":"Monday, 16 February 2026","event_location":"Paris, St Antoiine","event_time":"13h-20h","footnotes":""},"categories":[10],"tags":[],"class_list":["post-3972","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-event"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Conf\u00e9rence du Pr Michel Sadelain pionnier de l&#039;immunoth\u00e9rapie pour le traitement par CAR-T cells des cancers du sang. - FHU CARE\u00b2<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fhucare.com\/fr\/event\/conference-du-pr-michel-sadelain-pionnier-de-limmunotherapie-pour-le-traitement-par-car-t-cells-des-cancers-du-sang\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Conf\u00e9rence du Pr Michel Sadelain pionnier de l&#039;immunoth\u00e9rapie pour le traitement par CAR-T cells des cancers du sang. - FHU CARE\u00b2\" \/>\n<meta property=\"og:description\" content=\"Conf\u00e9rence du Pr Michel Sadelain \u2013 Fondation de l\u2019AP\u2011HP La Fondation de l\u2019AP\u2011HP a le plaisir d\u2019accueillir le Pr Michel Sadelain, m\u00e9decin\u2011chercheur de renomm\u00e9e internationale et pionnier des th\u00e9rapies par CAR\u2011T cells dans les cancers du sang. Il dirige la Columbia Initiative in Cell Engineering and Therapy \u00e0 l\u2019Universit\u00e9 Columbia. Revoir le Replay : Pr [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fhucare.com\/fr\/event\/conference-du-pr-michel-sadelain-pionnier-de-limmunotherapie-pour-le-traitement-par-car-t-cells-des-cancers-du-sang\/\" \/>\n<meta property=\"og:site_name\" content=\"FHU CARE\u00b2\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-16T16:55:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-23T12:43:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fhucare.com\/wp-content\/uploads\/2026\/02\/michel-sadelain.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"720\" \/>\n\t<meta property=\"og:image:height\" content=\"404\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Myriam Morcel\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Myriam Morcel\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/event\\\/conference-du-pr-michel-sadelain-pionnier-de-limmunotherapie-pour-le-traitement-par-car-t-cells-des-cancers-du-sang\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/event\\\/conference-du-pr-michel-sadelain-pionnier-de-limmunotherapie-pour-le-traitement-par-car-t-cells-des-cancers-du-sang\\\/\"},\"author\":{\"name\":\"Myriam Morcel\",\"@id\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/#\\\/schema\\\/person\\\/92f0f72be64f0653b8edcf67317340fa\"},\"headline\":\"Conf\u00e9rence du Pr Michel Sadelain pionnier de l&rsquo;immunoth\u00e9rapie pour le traitement par CAR-T cells des cancers du sang.\",\"datePublished\":\"2026-02-16T16:55:46+00:00\",\"dateModified\":\"2026-02-23T12:43:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/event\\\/conference-du-pr-michel-sadelain-pionnier-de-limmunotherapie-pour-le-traitement-par-car-t-cells-des-cancers-du-sang\\\/\"},\"wordCount\":551,\"publisher\":{\"@id\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/event\\\/conference-du-pr-michel-sadelain-pionnier-de-limmunotherapie-pour-le-traitement-par-car-t-cells-des-cancers-du-sang\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fhucare.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/michel-sadelain.jpg\",\"articleSection\":[\"Event\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/event\\\/conference-du-pr-michel-sadelain-pionnier-de-limmunotherapie-pour-le-traitement-par-car-t-cells-des-cancers-du-sang\\\/\",\"url\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/event\\\/conference-du-pr-michel-sadelain-pionnier-de-limmunotherapie-pour-le-traitement-par-car-t-cells-des-cancers-du-sang\\\/\",\"name\":\"Conf\u00e9rence du Pr Michel Sadelain pionnier de l'immunoth\u00e9rapie pour le traitement par CAR-T cells des cancers du sang. - FHU CARE\u00b2\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/event\\\/conference-du-pr-michel-sadelain-pionnier-de-limmunotherapie-pour-le-traitement-par-car-t-cells-des-cancers-du-sang\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/event\\\/conference-du-pr-michel-sadelain-pionnier-de-limmunotherapie-pour-le-traitement-par-car-t-cells-des-cancers-du-sang\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fhucare.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/michel-sadelain.jpg\",\"datePublished\":\"2026-02-16T16:55:46+00:00\",\"dateModified\":\"2026-02-23T12:43:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/event\\\/conference-du-pr-michel-sadelain-pionnier-de-limmunotherapie-pour-le-traitement-par-car-t-cells-des-cancers-du-sang\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fhucare.com\\\/fr\\\/event\\\/conference-du-pr-michel-sadelain-pionnier-de-limmunotherapie-pour-le-traitement-par-car-t-cells-des-cancers-du-sang\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/event\\\/conference-du-pr-michel-sadelain-pionnier-de-limmunotherapie-pour-le-traitement-par-car-t-cells-des-cancers-du-sang\\\/#primaryimage\",\"url\":\"https:\\\/\\\/fhucare.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/michel-sadelain.jpg\",\"contentUrl\":\"https:\\\/\\\/fhucare.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/michel-sadelain.jpg\",\"width\":720,\"height\":404},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/event\\\/conference-du-pr-michel-sadelain-pionnier-de-limmunotherapie-pour-le-traitement-par-car-t-cells-des-cancers-du-sang\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Conf\u00e9rence du Pr Michel Sadelain pionnier de l&rsquo;immunoth\u00e9rapie pour le traitement par CAR-T cells des cancers du sang.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/\",\"name\":\"FHU CARE\u00b2\",\"description\":\"Innovations in Autoimmunity, Cancer &amp; Immunotherapies\",\"publisher\":{\"@id\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/#organization\"},\"alternateName\":\"CARE2\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/#organization\",\"name\":\"FHU CARE\u00b2\",\"alternateName\":\"CARE2\",\"url\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/fhucare.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/CARE2-COULEUR.svg\",\"contentUrl\":\"https:\\\/\\\/fhucare.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/CARE2-COULEUR.svg\",\"caption\":\"FHU CARE\u00b2\"},\"image\":{\"@id\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/in\\\/fhucare\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@fhucare\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/fhucare.com\\\/fr\\\/#\\\/schema\\\/person\\\/92f0f72be64f0653b8edcf67317340fa\",\"name\":\"Myriam Morcel\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Conf\u00e9rence du Pr Michel Sadelain pionnier de l'immunoth\u00e9rapie pour le traitement par CAR-T cells des cancers du sang. - FHU CARE\u00b2","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fhucare.com\/fr\/event\/conference-du-pr-michel-sadelain-pionnier-de-limmunotherapie-pour-le-traitement-par-car-t-cells-des-cancers-du-sang\/","og_locale":"fr_FR","og_type":"article","og_title":"Conf\u00e9rence du Pr Michel Sadelain pionnier de l'immunoth\u00e9rapie pour le traitement par CAR-T cells des cancers du sang. - FHU CARE\u00b2","og_description":"Conf\u00e9rence du Pr Michel Sadelain \u2013 Fondation de l\u2019AP\u2011HP La Fondation de l\u2019AP\u2011HP a le plaisir d\u2019accueillir le Pr Michel Sadelain, m\u00e9decin\u2011chercheur de renomm\u00e9e internationale et pionnier des th\u00e9rapies par CAR\u2011T cells dans les cancers du sang. Il dirige la Columbia Initiative in Cell Engineering and Therapy \u00e0 l\u2019Universit\u00e9 Columbia. Revoir le Replay : Pr [&hellip;]","og_url":"https:\/\/fhucare.com\/fr\/event\/conference-du-pr-michel-sadelain-pionnier-de-limmunotherapie-pour-le-traitement-par-car-t-cells-des-cancers-du-sang\/","og_site_name":"FHU CARE\u00b2","article_published_time":"2026-02-16T16:55:46+00:00","article_modified_time":"2026-02-23T12:43:52+00:00","og_image":[{"width":720,"height":404,"url":"https:\/\/fhucare.com\/wp-content\/uploads\/2026\/02\/michel-sadelain.jpg","type":"image\/jpeg"}],"author":"Myriam Morcel","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Myriam Morcel","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fhucare.com\/fr\/event\/conference-du-pr-michel-sadelain-pionnier-de-limmunotherapie-pour-le-traitement-par-car-t-cells-des-cancers-du-sang\/#article","isPartOf":{"@id":"https:\/\/fhucare.com\/fr\/event\/conference-du-pr-michel-sadelain-pionnier-de-limmunotherapie-pour-le-traitement-par-car-t-cells-des-cancers-du-sang\/"},"author":{"name":"Myriam Morcel","@id":"https:\/\/fhucare.com\/fr\/#\/schema\/person\/92f0f72be64f0653b8edcf67317340fa"},"headline":"Conf\u00e9rence du Pr Michel Sadelain pionnier de l&rsquo;immunoth\u00e9rapie pour le traitement par CAR-T cells des cancers du sang.","datePublished":"2026-02-16T16:55:46+00:00","dateModified":"2026-02-23T12:43:52+00:00","mainEntityOfPage":{"@id":"https:\/\/fhucare.com\/fr\/event\/conference-du-pr-michel-sadelain-pionnier-de-limmunotherapie-pour-le-traitement-par-car-t-cells-des-cancers-du-sang\/"},"wordCount":551,"publisher":{"@id":"https:\/\/fhucare.com\/fr\/#organization"},"image":{"@id":"https:\/\/fhucare.com\/fr\/event\/conference-du-pr-michel-sadelain-pionnier-de-limmunotherapie-pour-le-traitement-par-car-t-cells-des-cancers-du-sang\/#primaryimage"},"thumbnailUrl":"https:\/\/fhucare.com\/wp-content\/uploads\/2026\/02\/michel-sadelain.jpg","articleSection":["Event"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/fhucare.com\/fr\/event\/conference-du-pr-michel-sadelain-pionnier-de-limmunotherapie-pour-le-traitement-par-car-t-cells-des-cancers-du-sang\/","url":"https:\/\/fhucare.com\/fr\/event\/conference-du-pr-michel-sadelain-pionnier-de-limmunotherapie-pour-le-traitement-par-car-t-cells-des-cancers-du-sang\/","name":"Conf\u00e9rence du Pr Michel Sadelain pionnier de l'immunoth\u00e9rapie pour le traitement par CAR-T cells des cancers du sang. - FHU CARE\u00b2","isPartOf":{"@id":"https:\/\/fhucare.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fhucare.com\/fr\/event\/conference-du-pr-michel-sadelain-pionnier-de-limmunotherapie-pour-le-traitement-par-car-t-cells-des-cancers-du-sang\/#primaryimage"},"image":{"@id":"https:\/\/fhucare.com\/fr\/event\/conference-du-pr-michel-sadelain-pionnier-de-limmunotherapie-pour-le-traitement-par-car-t-cells-des-cancers-du-sang\/#primaryimage"},"thumbnailUrl":"https:\/\/fhucare.com\/wp-content\/uploads\/2026\/02\/michel-sadelain.jpg","datePublished":"2026-02-16T16:55:46+00:00","dateModified":"2026-02-23T12:43:52+00:00","breadcrumb":{"@id":"https:\/\/fhucare.com\/fr\/event\/conference-du-pr-michel-sadelain-pionnier-de-limmunotherapie-pour-le-traitement-par-car-t-cells-des-cancers-du-sang\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fhucare.com\/fr\/event\/conference-du-pr-michel-sadelain-pionnier-de-limmunotherapie-pour-le-traitement-par-car-t-cells-des-cancers-du-sang\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/fhucare.com\/fr\/event\/conference-du-pr-michel-sadelain-pionnier-de-limmunotherapie-pour-le-traitement-par-car-t-cells-des-cancers-du-sang\/#primaryimage","url":"https:\/\/fhucare.com\/wp-content\/uploads\/2026\/02\/michel-sadelain.jpg","contentUrl":"https:\/\/fhucare.com\/wp-content\/uploads\/2026\/02\/michel-sadelain.jpg","width":720,"height":404},{"@type":"BreadcrumbList","@id":"https:\/\/fhucare.com\/fr\/event\/conference-du-pr-michel-sadelain-pionnier-de-limmunotherapie-pour-le-traitement-par-car-t-cells-des-cancers-du-sang\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/fhucare.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Conf\u00e9rence du Pr Michel Sadelain pionnier de l&rsquo;immunoth\u00e9rapie pour le traitement par CAR-T cells des cancers du sang."}]},{"@type":"WebSite","@id":"https:\/\/fhucare.com\/fr\/#website","url":"https:\/\/fhucare.com\/fr\/","name":"FHU CARE\u00b2","description":"Innovations in Autoimmunity, Cancer &amp; Immunotherapies","publisher":{"@id":"https:\/\/fhucare.com\/fr\/#organization"},"alternateName":"CARE2","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fhucare.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/fhucare.com\/fr\/#organization","name":"FHU CARE\u00b2","alternateName":"CARE2","url":"https:\/\/fhucare.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/fhucare.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/fhucare.com\/wp-content\/uploads\/2025\/11\/CARE2-COULEUR.svg","contentUrl":"https:\/\/fhucare.com\/wp-content\/uploads\/2025\/11\/CARE2-COULEUR.svg","caption":"FHU CARE\u00b2"},"image":{"@id":"https:\/\/fhucare.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/in\/fhucare\/","https:\/\/www.youtube.com\/@fhucare\/"]},{"@type":"Person","@id":"https:\/\/fhucare.com\/fr\/#\/schema\/person\/92f0f72be64f0653b8edcf67317340fa","name":"Myriam Morcel"}]}},"_links":{"self":[{"href":"https:\/\/fhucare.com\/fr\/wp-json\/wp\/v2\/posts\/3972","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fhucare.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fhucare.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fhucare.com\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/fhucare.com\/fr\/wp-json\/wp\/v2\/comments?post=3972"}],"version-history":[{"count":3,"href":"https:\/\/fhucare.com\/fr\/wp-json\/wp\/v2\/posts\/3972\/revisions"}],"predecessor-version":[{"id":4559,"href":"https:\/\/fhucare.com\/fr\/wp-json\/wp\/v2\/posts\/3972\/revisions\/4559"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fhucare.com\/fr\/wp-json\/wp\/v2\/media\/3970"}],"wp:attachment":[{"href":"https:\/\/fhucare.com\/fr\/wp-json\/wp\/v2\/media?parent=3972"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fhucare.com\/fr\/wp-json\/wp\/v2\/categories?post=3972"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fhucare.com\/fr\/wp-json\/wp\/v2\/tags?post=3972"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}